Our laboratory also recently reported that strong ERK5 expression in surgical RCC specimens was associated with high recurrence rates, and that ERK5 inhibition decreased cell proliferation and survival in ccRCC cells [17]. Here, MAPK7 is linked to nonpapillary renal cell carcinoma.